The tau biomarker cascade is condensed in Down syndrome compared with sporadic Alzheimer’s disease
Brain · 2026
DOI: 10.1093/brain/awaf428 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Brain, 2026. Verfasst von Matthew D Zammit und 34 weiteren Autor:innen. Beteiligte Einrichtung: Waisman Center, University of Wisconsin-Madison, Madison, WI 53705, USA. Hauptthemen laut MEDLINE: Down Syndrome, tau Proteins, Alzheimer Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, CPFT, NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Characterizing the timing and progression of Alzheimer’s disease biomarker onset in Down syndrome (DS) and contrasting potential timing differences with neurotypical adults is needed to identify optimal Alzheimer’s disease therapeutic treatment windows in DS. In this study, 198 adults with DS from the Alzheimer Biomarker Consortium–Down Syndrome and 172 neurotypical adults from the Wisconsin Registry for Alzheimer’s Prevention with available longitudinal beta-amyloid PET, tau PET and plasma p-tau217 analysed on the Lilly Meso Scale Delivery Platform were included. Individuals with DS had a significantly higher lifetime risk of beta-amyloid plaque onset. Temporal modelling of longitudinal biomarker measures revealed earlier age at positivity of beta-amyloid plaques, p-tau217 and neurofibrillary tau tangles in DS relative to the neurotypical cohort. The onset of p-tau217 and tau PET positivity in DS occurred nearly simultaneously, roughly 4–6 years following beta-amyloid onset, whereas the neurotypical group displayed greater temporal latency between positivity of the two biomarkers. The early and simultaneous onset of these biomarkers in DS highlights the necessity for early therapeutic interventions in this population. This work, combined with the upcoming anti-amyloid safety and efficacy clinical trials for DS will help to identify optimal treatment windows for these individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Waisman Center, University of Wisconsin-Madison, Madison, WI 53705, USA.
- Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA.
- Department of Medical Physics, University of Wisconsin-Madison, Madison, WI 53705, USA.
- Department of Medicine, University of Wisconsin-Madison, Madison, WI 53792, USA.
- Clinical Memory Research Unit, Lund University, Lund 221 00, Sweden.
- Department of Radiology, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA.
ORCID-Profile: Matthew D Zammit, Karly A Cody, Oskar Hansson, Patrick J Lao, Elizabeth Head, Tobey J Betthauser
Förderung
- NCATS NIH HHS
- CPFT
- NIA NIH HHS
- National Institutes of Health Programs
- Fulbourn Hospital, Cambridge
- Alzheimer Biomarkers Consortium-Down Syndrome
- ODCDC CDC HHS
- Windsor Research Unit
Zitieren
APA
Zammit, M. D., Bruzzone, H., Cody, K. A., Morse, J., Wilson, R., Bettcher, B. T., McLachlan, M. J., McVea, A. K., DiFilippo, A. H., Carey, F. J., Janelidze, S., Hansson, O., Price, J. C., Laymon, C. M., Minhas, D. S., Luo, W., Rosas, H. D., Lai, F., Lee, J. H., …, & Alzheimer Biomarker Consortium–Down Syndrome (2026). The tau biomarker cascade is condensed in Down syndrome compared with sporadic Alzheimer’s disease. Brain. https://doi.org/10.1093/brain/awaf428
Vancouver
Zammit MD, Bruzzone H, Cody KA, Morse J, Wilson R, Bettcher BT, et al. The tau biomarker cascade is condensed in Down syndrome compared with sporadic Alzheimer’s disease. Brain. 2026. doi:10.1093/brain/awaf428
BibTeX
@article{Zammit2026,
author = {Zammit, Matthew D and Bruzzone, Hailey and Cody, Karly A and Morse, Jacob and Wilson, Rachael and Bettcher, Brecca T and McLachlan, Max J and McVea, Andrew K and DiFilippo, Alexandra H and Carey, Finnuella J and Janelidze, Shorena and Hansson, Oskar and Price, Julie C and Laymon, Charles M and Minhas, Davneet S and Luo, Weiquan and Rosas, H Diana and Lai, Florence and Lee, Joseph H and Lao, Patrick J and Ances, Beau M and Krinsky-McHale, Sharon J and Hom, Christy L and Hartley, Sigan L and Zaman, Shahid H and Johnson, Sterling C and Cohen, Ann D and Head, Elizabeth and Mapstone, Mark E and Handen, Benjamin L and Christian, Bradley T and Tudorascu, Dana L and Langhough, Rebecca E and Betthauser, Tobey J and Alzheimer Biomarker Consortium–Down Syndrome, Alzheimer Biomarker Consortium–Down Syndrome},
title = {The tau biomarker cascade is condensed in Down syndrome compared with sporadic Alzheimer’s disease},
journal = {Brain},
year = {2026},
doi = {10.1093/brain/awaf428}
}
EUVIMED